IPO of Ami Organics Limited will be live for subscription from September 1st, 2021 and this issue will last till September 3rd, 2021. Ami Organics' IPO price band has been set at Rs.603 to Rs.610 by the company's promoters. In the grey market, shares of the specialty chemical stock are currently available at a premium of Rs.50.
With GEPL Capital’s IPO portal you can easily invest in ami organics as well as other active IPOs. We value your time that's why just click here and you'll be redirected to our IPO Investment Portal and with a few clicks, you'll be able to subscribe for the IPO of Ami organics.
Ami Organics Limited, founded in 2004, is a prominent specialty chemical manufacturer focused on research and development. Material for agrochemicals and fine chemicals, as well as Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API) for New Chemical Entities, are manufactured by the company.
Over 450 pharmaceutical intermediates have been produced by the business in 17 therapeutic categories, including antiretroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It serves over 150 customers (including foreign customers) directly in India and in 25 countries across the world, including Europe, the United States, China, Israel, Japan, Latin America, and others. Domestic customers include Laurus Labs, Cadila Healthcare, and Cipla Ltd, while international customers include Organike s.r.l.a. Socio Unico, Fermion Oly, Medichem S.A., and Midas Pharma GmbH.
Ami Organics is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib, and Rivaroxaban. The Pharma Intermediates which they manufacture, find application in certain high-growth therapeutic areas including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, antiParkinson, anti-depressant, and anti-coagulant, commanding significant market share both in India and globally. They have developed and commercialized over 450 Pharma Intermediates for APIs across 17 key therapeutic areas since inception. Currently, Ami Organics has 8 process patent applications and 3 additional pending process patent applications for which applications were made recently, in March 2021.
|Opening Date Of IPO||
Sep 1, 2021
|Closing Date Of IPO||
Sep 3, 2021
Rs.10 per equity share
Book Built Issue IPO
Rs.603 to Rs.610 per equity share
Strengths of the Ami Organics IPO:-
Valuation & Recommendation:
By pursuing strategic acquisitions including the recently concluded acquisition of the business of GOL, they will add to their capabilities and technical expertise or enter into partnerships to strengthen their product infrastructure and overall manufacturing capabilities in the specialty chemicals sector.
They intend to develop, test and manufacture new products meeting regulatory standards subsequent to receipt of requisite regulatory approvals from the relevant authorities in India and overseas and make investments on an ongoing basis in new product launches and research and development for future products.
They also intend to invest in the development of products that are used in the manufacture of APIs being used in formulations whose patents are expiring. We recommend a subscribe rating to the issue
Are you wandering here and there to find out what are the best stocks to buy in India for the short-term 2021? Well, we got your back for that. With ...Read More
With reference to the SEBI circular dated 20th July 2020, Peak Margin has been introduced in the Equity, Commodity & Currency segment from 1st December 2020. W.e.f 1st June 2021, there ...Read More
The private placement of Tata Motors comes with a coupon of 9.10 percent. The private placement of Tata Motors Finance Ltd (TMFL) comes with a coupon of 9.10 percent. The private placement of ...Read More